Hong kong launches massive trial to stop osteoporosis before it starts
NCT ID NCT07611097
First seen May 28, 2026 · Last updated Jun 22, 2026 · Updated 5 times
Summary
This study tests whether a structured exercise program, combined with an AI chatbot and incentives, can prevent osteoporosis and sarcopenia in adults aged 40-60. Over 8,300 participants will be randomly assigned to either the active program or standard advice. The trial will track fractures, muscle strength, and cost-effectiveness for up to 10 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Queen Mary Hospital, The University of Hong Kong, Hong Kong,
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
structured exercise program, AI chatbot, and incentives
What this could lead to
If successful, this could provide a proven, cost-effective way to prevent fractures and muscle loss in middle-aged adults, reducing the need for medication.
What could go wrong
This is a large but early-stage prevention trial. The intervention is behavioral, so results depend on long-term adherence. It may not show significant benefits over standard advice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.